Barbara Vickrey is a natural scientist (affiliated adjunct staff) at the RAND Corporation, professor of neurology at the University of California, Los Angeles (UCLA), and a staff physician and associate director of the Parkinson's Disease Research, Education, and Clinical Center at the VA Greater Los Angeles.
Vickrey's research focuses on translating evidence from clinical trials into routine medical practice and improved patient health outcomes. She led a multi-site randomized trial that demonstrated substantially improved quality and better patient and caregiver outcomes from a "re-engineered," collaborative approach to dementia care delivery that engaged healthcare systems, community organizations, and patient/caregiver dyads. Ongoing research is creating and testing innovations in care delivery for post-stroke risk factor control in the Los Angeles County safety net healthcare system, and for Parkinson's disease care in the VA. These models aim to improve quality while improving efficiency through information technology, decision support, and community partnerships. At RAND, she co-leads a comparative effectiveness trial to analyze the benefits and costs of two approaches for coordinated dementia care delivery in a predominantly Hispanic community served by the Los Angeles County public healthcare system. She has served on several strategic planning/advisory panels to the National Institute of Neurological Disorders and Stroke.
Vickrey received her M.D. from Duke University and her M.P.H. from UCLA. Her research training included fellowships in the UCLA Robert Wood Johnson Clinical Scholars Program and at the RAND/UCLA Center for Health Policy Study.
Concurrent Non-RAND PositionsProfessor of Neurology, University of California, Los Angeles; Associate Director of Parkinson's Disease Research, Education, and Clinical Center at the VA Greater Los Angeles HealthCare System
- Comparative effectiveness trials of chronic care model-based approaches for dementia, stroke risk factor control, and Parkinson's disease
- Development of measures of quality and outcomes of care for neurological diseases, including Parkinson's disease, multiple sclerosis, and epilepsy
- Cost and occurrence of recurrent atherosclerotic events
Vickrey BG, Hirtz D, Waddy S, Cheng EM, Johnston SC., "Comparative effectiveness and implementation research: Directions for neurology," Annals of Neurology, 71:732-742, 2012
Chiong-Rivero H, Ryan GW, Flippen C, Bordelon Y, Szumski NR, Zesiewicz TA, Vassar S, Weidmer B, Garcia RE, Bradley M, Vickrey BG., "Patients' and caregivers' experiences of the impact of Parkinson's Disease on health status.," Patient Related Outcome Measures, 2:57-70, 2011
Cheng EM, Crandall CJ, Bever C, Giesser B, Haselkorn J, Hays RD, Shekelle P, Vickrey BG., "Quality indicators for multiple sclerosis.," Multiple Sclerosis, 16:970-980, 2010
Vickrey BG, Mittman BS, Connor KI, Pearson ML, Della Penna RD, Ganiats TG, DeMonte RW, Chodosh J, Cui X, Vassar S, Duan N, Lee M., "The effect of a disease management intervention on quality and outcomes of dementia care: A randomized controlled trial.," Annals of Internal Medicine, 145:713-726, 2006
Sloss EM, Wickstrom SL, McCaffrey DF, Garber S, Rector TS, Levin RA, Guzy PM, Gorelick PB, Dake MD, Vickrey BG., "Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditions.," Cerebrovascular Diseases, 18:8-15, 2004
Honors & Awards
- Elected to the Institute of Medicine of the National Academies
- Alice S. Hersh Young Investigator Award, AcademyHealth